13 South Dakota clinics receive products from company linked to meningitis outbreak
The South Dakota Department of Health has contacted 13 health care facilities identified as receiving drugs from a Massachusetts firm linked to the nationwide meningitis outbreak.
New England Compounding Center (NECC) is the company that produced the steroids linked to the outbreak. South Dakota has not had any reported cases of meningitis linked to the outbreak, but it is not known at this time how many patients in South Dakota received NECC products.
The clinics identified as receiving pharmaceuticals from NECC were identified this week based on information provided by the FDA. The clinics include:
Brookings Ambulatory Surgery Center LLP, Brookings
Bruening Eye Specialists, Dakota Dunes
Siouxland Surgery Center, Dakota Dunes
Anderson Orthopedics, Rapid City
Black Hills Plastic Surgery, Rapid City
Black Hills Regional Eye Institute, Rapid City
Black Hills Surgical Hospital, Rapid City
Rapid City Medical Center, Rapid City
Rapid City Regional Hospital, Rapid City
Sanford Clinic for Ophthalmology and Optometry, Sioux Falls
Dakota Dermatology, Sioux Falls
Lazaderm Skincare Centre, Sioux Falls
Innovative Procedural Center, Watertown
"We have contacted every South Dakota facility identified as receiving drugs on this week's expanded recall list," said Bonnie Jameson, Disease Prevention Administrator for the department. "We've instructed them to suspend use of the NECC products and notify any patients who had received them to be alert for the signs and symptoms of infection, including meningitis."
Jameson said the department has also issued a health alert to providers statewide asking them to review purchasing records and inventory to make sure they have not received any NECC products on the recall list.
The signs and symptoms of meningitis include fever, headache, stiff neck, nausea and vomiting, sensitivity to light and altered mental status. Symptoms for other possible infections may include fever; swelling, increasing pain, redness, warmth at injection site; visual changes, pain, redness or discharge from the eye; chest pain, or drainage from the surgical site.